Kyphon to Divest Assets to J&J

The FTC has received a petition to approve Kyphon’s divestiture of certain assets it acquired through a merger with Disc-O-Tech.

The divestiture is required under an FTC order alleging the merger would substantially reduce competition in the U.S. market for minimally invasive vertebral compression fracture treatment products.

According to the petition, Kyphon has requested approval to divest the Confidence assets to DePuy Spine, a Johnson & Johnson (J&J) company.